Klaus Welzel, Senior Consultant – Frankfurt, has passed away

Jul 23, 2012

Los Angeles, California The Plexus Ventures team is saddened to announce that Klaus Welzel PhD., Senior Consultant – Frankfurt, passed away on July 23, 2012. Klaus is survived by his wife Renate, three adult children, and two grandchildren. The funeral was held on July 30 in Oberstedten, Germany.

Klaus joined Plexus Ventures in 2005 after a distinguished career; he worked for Eli Lilly for 21 years and for 10 years at Schwarz Pharma. During his 8 year tenure at Plexus Ventures, Klaus was instrumental in several projects and transactions managed by our firm. Dr. Welzel founded the Frankfurt, Germany office of Plexus Ventures.

Klaus will be missed as a valued colleague, team member and friend. A memorial contribution was made in his honor to SOS Children’s Villages, at the request of the family.

About Plexus Ventures

Plexus Ventures has earned the title Business Builders in Healthcare over nearly three decades as a leading corporate and business development consultancy for healthcare industry companies. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives. Plexus industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.



Celon Pharma enters agreement with Zydus Lifesciences Ltd.

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...